Capítulo 8. 6. Síndrome febril. Aproximación diagnóstica y terapéutica

Bibliografía 

1.  Pachón J, Viciana P. Fiebre sin focalidad en Urgencias. En: Picazo JJ, Romero J, eds. Infecciones en Urgencias. Madrid: Eurobook, 1996; 1-14.
2.  Dinarello CA, Wolff SM. Patogenia de la fiebre. En: Mandell GL, Douglas RG, Bennett JE, eds. Enfermedades Infecciosas: principios y práctica. Buenos Aires: Panamericana, 1991; 485-491.
3.  Bernheim HA, Block LH, Atkins E. Fever: pathogenesis, pathophysiology, and purpose. Ann Intern Med 1979; 91:261-270.
4.  Battestini R, Betés M, Gómez R, San Román CM. Efectos nocivos causados por la luz y las radiaciones. En: Rozman C, ed. Farreras-Rozman: Medicina Interna. Madrid: Mosby-Doyma, 1995; 2636-2649.
5.  Speck EL, Murray HW. Fiebre y fiebre de etiología desconocida. En: Reese RE, Betts RF, eds. Un planteamiento práctico de las enfermedades infecciosas. Madrid: Jarpyo, 1991; 1-20. 
6.  Coto A. Síndrome febril. En: Medina J, ed. Manual de Urgencias Médicas. Madrid: Díaz de Santos, 1997; 87-92.
7.  Gantz NM, Brown RB, Berk SL, Esposito AL, Gleckman RA. Hyperpyrexia and hyperthermia. In: Gantz NM, Brown RB, Berk SL, Esposito AL, Gleckman RA, eds. Manual of clinical problems in infectious disease. Boston: Little Brown, 1994; 258-264.
8.  Jiménez-Mejías ME, Montaño M, Villalonga J, Bollaín E, López-Pardo F, Pineda JA, et al. Golpe de calor clásico en España: Análisis de una serie de 78 casos. Med Clin (Barc) 1990; 94:481-486.
9.  Nelson TE, Flewellen EH. Current concepts. The malignant hyperthermia syndrome. N Engl J Med 1983; 309:416-418.
10.  Guzé BH, Baxter LR Jr. Current concepts: neuroleptic malignant syndrome. N Engl J Med 1985; 313:163-166.
11.  Simon HB. Current Concepts: hyperthermia. N Engl J Med 1993; 329:483-487. 
12.  Gantz NM, Brown RB, Berk SL, Esposito AL, Gleckman RA. Fever of unknown origin. In: Gantz NM, Brown RB, Berk SL, Esposito AL, Gleckman RA, eds. Manual of clinical problems in infectious disease. Boston: Little Brown, 1994; 269-274.
13.  Aduan RP, Fauci AS, Dale DC, Herzberg JH, Wolff SM. factitious fever and self-induced infection. Ann Intern Med 1979; 90:230-242.
14.  Dinarello CA, Wolff SM. Fever of unknown origin. En: Mandell GL, Douglas RG, Bennett JE, eds. Principle and practice of infectious diseases, 3.ª ed. Nueva York, Churchill Livingstone, 1990;468-478.
15.  Knockaert DC, Vanneste LJ, Bobbaers HJ. Recurrent or episodic fever of unknown origin. Medicine 1993; 72:184-196.
16.  Larson EB, Featherstone HJ, Petersdorf RG. Fever of undetermined origin: diagnosis and follow up of 105 cases, 1970-1980. Medicine 1982; 61:269-292.
17.  Weinstein L. Clinically benign fever of unknown origin: a personal retrospective. Rev Infect Dis 1985; 7:692-698.
18.  Petersdorf RG, Larson EB. An Overview. En: Murray HW, ed. FUO: Fever of Undetermined Origin. New YorK: Futura 1983; 3-7. 
19.  Johnson III JE. Drug Fever. En: Murray HW, ed. FUO: Fever of Undetermined Origin. New YorK: Futura 1983; 67-86.
20.  Musher DM, Fainstein V, Young EJ, Pruett TL. Fever Patterns: their lack of clinical significance. Arch Intern Med 1979; 139:1225-1228.
21.  Gantz NM, Brown RB, Berk SL, Esposito AL, Gleckman RA. The febrile patient without obvious source of infection. In: Gantz NM, Brown RB, Berk SL, Esposito AL, Gleckman RA, eds.  Manual of clinical problems in infectious disease. Boston: Little Brown, 1994; 229-232.
22.  Leibovici L, Cohen O, Wysenbeek AJ. Occult bacterial infection in adults with unexplained fever. Arch Intern Med 1990; 150:1270-1272.
23.  Viciana P. Síndrome febril de duración intermedia de la comunidad: estudio etiológico prospectivo durante los años 1983-1989. Tesis doctoral, Universidad de Sevilla, 1991, 240 p.
24.  Viciana P, pachón J, Cuello JA, Palomino J, Jiménez-Mejías ME, Cisneros JM. Fever of Intermediate Duration in the Community. A seven Years Study in the South of Spain. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. October, 11-14, 1992. American Society for Microbiology, Washington, DC. Abstract n.º 683.
25.  Petersdorf RG, Beeson PB. Fever of unexplained origin: Report of 100 cases. Medicine (Baltimore) 1961; 40:1-60.
26.  Brusch JL, Weinstein L. fever of unknown origin. Med Clin North Am 1988; 72: 1247-1261.
27.  DuracK DT, Street AC. Fever of unknown origin reexamined and redefined. En: Remington J, Swartz M, eds. Current Clinical Topics in Infectious Diseases. St. Louis; Mosby-Year Book, 1991;35-51.
28.  Kluger MJ, Kauffman CA. Biologic Mechanisms of Fever. En: Murray HW, ed. FUO: Fever of Undetermined Origin. New YorK: Futura 1983; 9-23.
29.  Root RK, Petersdorf G. Fiebre y escalofríos. En: Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK, eds. Harrison: principios de Medicina Interna. Madrid: McGraw-Hill-Interamericana, 1991; 146-156.
30.  Pittman AM. Cuidados del paciente en medicina interna. En: Woodley M, Whelan A, eds. Manual de terapéutica médica. Barcelona: Masson-Salvat, 1993; 1-30.
31.  Goodenberger D. Urgencias médicas. En: Woodley M, Whelan A, eds. Manual de terapéutica médica. Barcelona: Masson-Salvat, 1993; 617-656.
32.  Kingston ME, Mackey D. Skin clues in the diagnosis of life-threatening infections. Rev Infect Dis 1986;8(1):1-11
33.  Schlossberg D. Fever and rash. Infect Dis Clin North Am 1996;10:101-110.
34.  Grossman ME, Silvers DN, Walther RR. Cutaneous manifestations of disseminated candidiasis.J Am Acad Dermatol 1980;2(2):111-116 
35.  Shatz DV, Norwood S. An aproach to the febrile ICU patient. En: Critical Care. Civetta JM, Taylor RW, Kirby RR. Lippincott-Raven Publishers. Philadelphia, 1997: 1589-1602.
36.  McDonell PJ, McDonell JM, Brown RH, Green WR. Ocular involvement in patients with fungal infections. Ophtalmology 1985;92:706-709.
37.  Ballinger R. CMV retinitis. Optom Vis Sci 1995;72:305-309
38.  Johnson MJ, Lucas GL. Fat embolism syndrome. Orthopedics 1996;19:41-48
39.  Tierney MR, Baker AS. Infections of the head and neck in diabetic patients. Infect Dis Clin North Am 1995;9:195-216
40.  Dickinson LD, Hoff JT. Infectious disease in neurosurgical intensive care. En: Andrews,BT. Neurosurgical intensive care. McGraw-Hill Inc. New York,1993: 201-226.
41.  Lanken PN. Respiratory failure: an overview. En: Carlson RW, Geheb MA. Principles and practice of medical intensive care. Philadelphia. MB Saunders Company, 1993: 754-62.
42.  Murray HW, Ellis GC, Blumenthal DS, Sos TA. Fever and pulmonary thromboembolism. Am J Med 1979;67:232-235.
43.  Johnson DH, Cunha, BA. Drug fever. Infect Dis Clin North Am 1996;10:85-91
44.  Meduri GU, Eltorky M, Winer-Muram HT. The fibroproliferative phase of late adult respiratory distress syndrome. Semin respir Infect 1995; 10:154-175
45.  DePaso WJ. Aspiration pneumonia. Clin Chest Med 1991;12:269-284.
46.  Brandt LJ. Acute mesenteric ischemia. En: Carlson RW, Geheb MA. Principles and practice of medical intensive care. Philadelphia. MB Saunders Company, 1993:1485-1489.
47.  Ringel AF, Jameson GL, Foster ES. Diarrhea in the intensive care patient.Crit Care Clin 1995 ;11:465-477 
48.  Lewitt PA, Berchou RC. Hyperpyretic-rigidity syndrome (neuroleptic malignant syndrome). En: Carlson RW, Geheb MA. Principles and practice of medical intensive care. Philadelphia. MB Saunders Company, 1993:698-705.
49.  Nussbaum ES, Rigamonti D, Standiford H, Numaguchi Y, Wolf AL, Robinson WL. Spinal epidural abscess: a report of 40 cases and review. Surg Neurol 1992 ;38:225-231 
50.  George MJ, Glew RH. Aproach to the fever in the intensive care patient. En: Rippe JM, Irwin RS, Alpert JS, Fink MP.Intensive care Medicine.Little, Brown and Company. Boston/Toronto/London, 1996:1085-1092.
51.  Mader JT, Mohan D, Calhoun J A practical guide to the diagnosis and management of bone and joint infections. Drugs 1997 ;54:253-264
52.  Godeau B, Boudjadja A, Dhainaut JF, Schlemmer B, Chastang C, Brunet F, Le Gall JR. Outcome of patients with systemic rheumatic disease admitted to medical intensive care units. Ann Rheum Dis. 1992 May 1; 51: 627-631.
53.  Hedstrom SA.Septic bone and joint infections.  Curr Opin Rheumatol. 1996;8: 322-326. 
54.  Lew DP, Waldvogel FA. Osteomyelitis. N Eng J Med 1997;336:999-1007.
55.  Elliott DC, Kufera JA, Myers RA. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg. 1996; 224: 672-683
56.  Singh U, Scheld WM. Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis 1996 ;22:642-649
57.  Vukmir RB. Aeromonas hydrophila: myofascial necrosis and sepsis. Intensive Care Med. 1992;18: 172-174.
58.  Farr BM. Infection control in intensive care units: modern problems, modern solutions. Curr Op Infect Dis 1993;6:520-525.
59.  Primera Conferencia de Consenso organizada por la SEMIUC. Infecciones por Catéter. Med Intensiva, 1996;20:202-206.
60.  Brook I, Frazier EH. Aerobic and anaerobic bacteriology of wounds and cutaneous abscesses. Arch Surg 1990;125:1445-1451
61.  Mattison LE, Coppage L, Alderman DF, Herlong JO, Sahn SA. Pleural effusions in the medical ICU: prevalence, causes, and clinical implications. Chest 1997;111:1018-1023
62.  Bleichner G, Boulanger R, Squara P, Sollet JP, Parent A. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage. Br J Surg 1986;73:724-726 
63.  Rosen MJ, Clayton K, Schneider RF, Fulkerson W, Rao AV, Stansell J, Kvale PA, Glassroth J, Reichman LB, Wallace JM, Hopewell PC Intensive care of patients with HIV infection: utilization, critical illnesses, and outcomes. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med. 1997;155: 67-71
64.  Ulibarrena M, Cortés J, Manzano A, Fonseca F, Corral E, Labayen F. La gammagrafía con leucocitos marcados en el diagnóstico de foco infeccioso en el paciente crítico. Med Intensiva; 8:342-345.